CTR Investments & Consulting Inc
CTR Investments & Consulting, Inc. provides information technology services and products used by customers in the financial, private, government, and health care sectors. It specializes in identity information and data assurance; visitor management; and security technologies, including hardware and software solutions for electronic visitor management. The company's products include BioKey ID iden… Read more
CTR Investments & Consulting Inc (CIVX) - Net Assets
Latest net assets as of January 2025: $-224.93K USD
Based on the latest financial reports, CTR Investments & Consulting Inc (CIVX) has net assets worth $-224.93K USD as of January 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($45.01K) and total liabilities ($269.94K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-224.93K |
| % of Total Assets | -499.79% |
| Annual Growth Rate | 22.4% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 35857.31 |
CTR Investments & Consulting Inc - Net Assets Trend (2005–2025)
This chart illustrates how CTR Investments & Consulting Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CTR Investments & Consulting Inc (2005–2025)
The table below shows the annual net assets of CTR Investments & Consulting Inc from 2005 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-10-31 | $2.81 Million | +71622.55% |
| 2006-10-31 | $3.92K | -92.06% |
| 2005-10-31 | $49.28K | -- |
Equity Component Analysis
This analysis shows how different components contribute to CTR Investments & Consulting Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 170609300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (October 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $3.71 Million | 132.01% |
| Other Comprehensive Income | $251.97K | 8.97% |
| Other Components | $799.83K | 28.48% |
| Total Equity | $2.81 Million | 100.00% |
CTR Investments & Consulting Inc Competitors by Market Cap
The table below lists competitors of CTR Investments & Consulting Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Eco-Tek Group Inc.
PINK:ETEK
|
$1.94 |
|
Tigrent Inc
PINK:TIGE
|
$1.94 |
|
Appswarm Inc
PINK:SWRM
|
$1.95 |
|
Sentisearch Inc
PINK:SSRC
|
$1.95 |
|
Big Buck Brewery & Steakhouse Inc
PINK:BBUCQ
|
$1.94 |
|
USA Performance Products Inc
PINK:UPRM
|
$1.94 |
|
Amaru Inc
PINK:AMRU
|
$1.94 |
|
Newberry Specialty Bakers Inc
PINK:NBRY
|
$1.93 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CTR Investments & Consulting Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2006 to 2025, total equity changed from 3,915 to 2,807,938, a change of 2,804,023 (71622.6%).
- Net loss of 277,917 reduced equity.
- Other comprehensive income increased equity by 251,965.
- Other factors increased equity by 2,829,975.
Equity Change Factors (2006 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-277.92K | -9.9% |
| Other Comprehensive Income | $251.97K | +8.97% |
| Other Changes | $2.83 Million | +100.78% |
| Total Change | $- | 71622.55% |
Book Value vs Market Value Analysis
This analysis compares CTR Investments & Consulting Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.26x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.11x to 0.26x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-10-31 | $0.00 | $0.00 | x |
| 2006-10-31 | $0.00 | $0.00 | x |
| 2025-10-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CTR Investments & Consulting Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -9.90%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -819.79%
- • Asset Turnover: 0.01x
- • Equity Multiplier: 1.25x
- Recent ROE (-9.90%) is above the historical average (-5831.89%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | -394.51% | -10991.29% | 0.04x | 1.00x | $-199.36K |
| 2006 | -17091.26% | -29965.20% | 0.16x | 3.66x | $-669.51K |
| 2025 | -9.90% | -819.79% | 0.01x | 1.25x | $-558.71K |
Industry Comparison
This section compares CTR Investments & Consulting Inc's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CTR Investments & Consulting Inc (CIVX) | $-224.93K | -394.51% | N/A | $1.94 |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |